U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06920641) titled 'Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults' on March 25.
Brief Summary: The primary objective of this clinical-trial is to determine, in subjects with impaired fasting glucose (IFG) and/or insulin resistance (IR), if tagatose meets the definition of a prebiotic, namely that consuming tagatose for 4 weeks selectively stimulates the selective growth of bacteria in the colon and is associated with a health benefit (oral glucose tolerance) when compared to consuming the control treatment (10g sucrose) for 4 weeks.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Glucos...